TY  - JOUR

T1  - 245P Palbociclib combined with aromatase inhibitors (AIs) in women ≥75 years with oestrogen receptor positive (ER+ve), human epidermal growth factor receptor 2 negative (HER2-ve) advanced breast cancer: A real-world multicentre UK study

JO  - Annals of Oncology

PY  - 2021/09/01

AU  - El Badri S

AU  - Tahir B

AU  - Balachandran K

AU  - Bezecny P

AU  - Britton F

AU  - DeSouza K

AU  - Hills D

AU  - Moe M

AU  - Pigott T

AU  - Proctor A

AU  - Shah Y et al

ED  - 

DO  - DOI: 10.1016/j.annonc.2021.08.528

PB  - Elsevier BV

VL  - 32

SP  - S466

EP  - S466

Y2  - 2025/10/10

ER  -